|
US2940972A
(en)
|
1957-06-27 |
1960-06-14 |
Thomae Gmbh Dr K |
Tri-and tetra-substituted pteridine derivatives
|
|
US2963481A
(en)
|
1959-11-27 |
1960-12-06 |
Smith Kline French Lab |
6-pteridinecarboxylic acid esters
|
|
DE2037693C3
(de)
|
1969-08-02 |
1975-01-16 |
Sumitomo Chemical Co., Ltd., Osaka (Japan) |
1-Cyclopropylmethyl-2(1 H)-chinazolinonderivate
|
|
JPH05170744A
(ja)
*
|
1991-12-25 |
1993-07-09 |
Toray Dow Corning Silicone Co Ltd |
含窒素芳香族複素環式化合物のアルキル化方法
|
|
JPH09510695A
(ja)
|
1994-01-03 |
1997-10-28 |
エイシア・ファーマシュウティカルズ，インコーポレイテッド |
８−アザ、６−アザ、および６，８−ジアザ−１，４−ジヒドロキノキサリン−２，３−ジオン類およびそのグリシン／ｎｍｄａリセプターに対するアンタゴニストとしての使用
|
|
PT1028950E
(pt)
|
1997-10-28 |
2003-09-30 |
Warner Lambert Co |
Quinazolina-2,4-dionas 7-substituidas uteis como agentes antibacterianos
|
|
US6667300B2
(en)
|
2000-04-25 |
2003-12-23 |
Icos Corporation |
Inhibitors of human phosphatidylinositol 3-kinase delta
|
|
JP2004521892A
(ja)
|
2000-12-20 |
2004-07-22 |
メルク エンド カムパニー インコーポレーテッド |
（ハロ−ベンゾカルボニル）複素環縮合フェニル系ｐ３８キナーゼ阻害剤
|
|
JP2003005355A
(ja)
|
2001-06-20 |
2003-01-08 |
Fuji Photo Film Co Ltd |
電子線又はｘ線用ネガ型レジスト組成物
|
|
EP1558585B1
(en)
|
2002-10-04 |
2013-09-25 |
Prana Biotechnology Limited |
Neurologically-active compounds
|
|
GB0229281D0
(en)
*
|
2002-12-16 |
2003-01-22 |
Novartis Ag |
Organic compounds
|
|
WO2005007099A2
(en)
|
2003-07-10 |
2005-01-27 |
Imclone Systems Incorporated |
Pkb inhibitors as anti-tumor agents
|
|
DE602004008312T2
(de)
|
2003-10-17 |
2008-04-17 |
4 Aza Ip Nv |
Heterocyclus-substituierte pteridin-derivate und ihre verwendung in der therapie
|
|
MXPA06005019A
(es)
*
|
2003-11-03 |
2006-07-06 |
Warner Lambert Co |
Nuevos inhibidores de la recaptacion de norpinefrina para el tratamiento de transtornos del sistema nervioso central.
|
|
UA83416C2
(en)
|
2004-02-13 |
2008-07-10 |
Баниу Фармасьютикал Ко., Лтд. |
Fused ring 4-oxopyrimidine derivative
|
|
WO2005087742A1
(en)
*
|
2004-03-08 |
2005-09-22 |
Exelixis, Inc. |
Metabolic kinase modulators and methods of use as pesticides
|
|
WO2005095360A1
(en)
|
2004-04-02 |
2005-10-13 |
Prana Biotechnology Limited |
Neurologically-active compounds
|
|
US20070054916A1
(en)
|
2004-10-01 |
2007-03-08 |
Amgen Inc. |
Aryl nitrogen-containing bicyclic compounds and methods of use
|
|
EP1871377A1
(en)
|
2005-02-25 |
2008-01-02 |
Kudos Pharmaceuticals Ltd |
2,4-diamino-pyridopyrimidine derivatives and their use as mtor inhibitors
|
|
WO2006128172A2
(en)
|
2005-05-26 |
2006-11-30 |
Synta Pharmaceuticals Corp. |
Method for treating b cell regulated autoimmune disorders
|
|
WO2006128129A2
(en)
|
2005-05-26 |
2006-11-30 |
Synta Pharmaceuticals Corp. |
Method for treating cancer
|
|
KR100659088B1
(ko)
|
2005-07-15 |
2006-12-21 |
삼성에스디아이 주식회사 |
디플루오로피리딘계 화합물 및 이를 이용한 유기 발광 소자
|
|
WO2007038331A2
(en)
|
2005-09-23 |
2007-04-05 |
Smithkline Beecham Corporation |
Novel chemical compounds
|
|
US20090082349A1
(en)
|
2006-03-02 |
2009-03-26 |
Dashyant Dhanak |
Thiazolones for use as pi3 kinase inhibitors
|
|
US7855194B2
(en)
*
|
2006-03-27 |
2010-12-21 |
Hoffmann-La Roche Inc. |
Pyrimidine, quinazoline, pteridine and triazine derivatives
|
|
WO2008003149A2
(en)
|
2006-07-06 |
2008-01-10 |
Gilead Sciences , Inc. |
Substituted pteridines for the treatment and prevention of viral infections
|
|
US7635683B2
(en)
|
2006-08-04 |
2009-12-22 |
Enanta Pharmaceuticals, Inc. |
Quinoxalinyl tripeptide hepatitis C virus inhibitors
|
|
PT2057156T
(pt)
|
2006-08-23 |
2017-05-04 |
Kudos Pharm Ltd |
Derivados de 2-metilmorfolina pirido-, pirazo- e pirimidopirimidina como inibidores de mtor
|
|
EP2142509B1
(en)
|
2007-04-18 |
2013-12-04 |
Amgen, Inc |
Quinolones and azaquinolones that inhibit prolyl hydroxylase
|
|
US20090099195A1
(en)
|
2007-05-08 |
2009-04-16 |
Astrazeneca Ab |
Therapeutic Compounds 570
|
|
KR20100089082A
(ko)
|
2007-10-15 |
2010-08-11 |
아스트라제네카 아베 |
조합 059
|
|
US20110098267A1
(en)
|
2008-02-07 |
2011-04-28 |
Synta Pharmaceuticals Corporation |
Topical formulations for the treatment of psoriasis
|
|
US8298825B1
(en)
|
2008-08-25 |
2012-10-30 |
The General Hospital Corporation |
TGF-beta receptor inhibitors to enhance direct reprogramming
|
|
WO2010033906A2
(en)
|
2008-09-19 |
2010-03-25 |
President And Fellows Of Harvard College |
Efficient induction of pluripotent stem cells using small molecule compounds
|
|
SMT202000257T1
(it)
|
2008-10-10 |
2020-07-08 |
Vm Discovery Inc |
Composizioni e metodi per il trattamento dei disturbi da uso di alcol, dolore e altre malattie
|
|
US20120022057A1
(en)
|
2009-03-18 |
2012-01-26 |
Schering Corporation |
Bicyclic compounds as inhibitors of diacyglycerol acyltransferase
|
|
US8691187B2
(en)
|
2009-03-23 |
2014-04-08 |
Eli Lilly And Company |
Imaging agents for detecting neurological disorders
|
|
EP2459558A2
(en)
|
2009-07-30 |
2012-06-06 |
Irm Llc |
Compounds and compositions as syk kinase inhibitors
|
|
WO2011014039A1
(en)
|
2009-07-31 |
2011-02-03 |
Rohm And Haas Electronic Materials Korea Ltd. |
Novel organic electroluminescent compounds and organic electroluminescent device using the same
|
|
WO2011037731A1
(en)
|
2009-09-25 |
2011-03-31 |
Anacor Pharmaceuticals, Inc. |
Boron containing small molecules
|
|
MX2012004846A
(es)
|
2009-10-29 |
2012-10-05 |
Genosco |
Inhibidores de cinasa.
|
|
MX2012010557A
(es)
*
|
2010-03-16 |
2012-10-05 |
Merck Patent Gmbh |
Morfolinilquinazolinas.
|
|
US9139592B2
(en)
|
2010-06-14 |
2015-09-22 |
Trt Pharma Inc. |
Modulators of Nrf2 and uses thereof
|
|
SG10201604497UA
(en)
|
2011-06-02 |
2016-07-28 |
Almac Diagnostics Ltd |
Molecular Diagnostic Test For Cancer
|
|
CN102887895B
(zh)
|
2011-07-22 |
2016-08-24 |
山东轩竹医药科技有限公司 |
吡啶并嘧啶类mTOR抑制剂
|
|
KR101497124B1
(ko)
|
2011-11-28 |
2015-03-06 |
덕산네오룩스 주식회사 |
유기전기소자용 화합물, 이를 포함하는 유기전기소자 및 그 전자 장치
|
|
JP6283320B2
(ja)
|
2012-02-08 |
2018-02-21 |
ヤンセン・サイエンシズ・アイルランド・ユーシー |
ウイルス感染の治療のためのピペリジノ−ピリミジン誘導体
|
|
CN103374021B
(zh)
|
2012-04-21 |
2015-10-28 |
通化济达医药有限公司 |
含有锌结合基的吡啶并嘧啶类HDAC和mTOR抑制剂
|
|
WO2014146249A1
(en)
*
|
2013-03-19 |
2014-09-25 |
Merck Sharp & Dohme Corp. |
Geminally substituted cyanoethylpyrazolo pyridones as janus kinase inhibitors
|
|
EP3027616B1
(en)
|
2013-07-30 |
2018-01-10 |
Boehringer Ingelheim International GmbH |
Azaindole compounds as modulators of rorc
|
|
EP3080085B1
(en)
|
2013-12-09 |
2019-08-14 |
UCB Biopharma SPRL |
Fused bicyclic heteroaromatic derivatives as modulators of tnf activity
|
|
KR20150080966A
(ko)
|
2014-01-02 |
2015-07-13 |
최돈수 |
유기 전기 발광 소자용 발광 재료, 이를 이용한 유기 전기 발광 소자 및 유기 전기 발광 소자용 재료
|
|
KR20160060572A
(ko)
|
2014-11-19 |
2016-05-30 |
주식회사 엠비케이 |
유기 발광 화합물, 잉크 조성물, 유기 발광 소자 및 전자 기기
|
|
SG11201708294YA
(en)
|
2015-04-15 |
2017-11-29 |
Hoffmann La Roche |
Pyridopyrimidinones and their use as nmda receptor modulators
|
|
US10403826B2
(en)
|
2015-05-07 |
2019-09-03 |
Universal Display Corporation |
Organic electroluminescent materials and devices
|
|
EP3335254B1
(de)
|
2015-08-11 |
2020-04-08 |
Merck Patent GmbH |
Materialien für organische elektrolumineszenzvorrichtungen
|
|
WO2017031427A1
(en)
|
2015-08-19 |
2017-02-23 |
3-V Biosciences, Inc. |
COMPOUNDS AND METHODS FOR INHIBITING mTOR
|
|
KR102606277B1
(ko)
|
2016-04-06 |
2023-11-27 |
삼성디스플레이 주식회사 |
유기 발광 소자
|
|
US10573692B2
(en)
|
2016-04-06 |
2020-02-25 |
Samsung Display Co., Ltd. |
Organic light-emitting device having a sealing thin film encapsulation portion
|
|
IL307931A
(en)
|
2016-04-15 |
2023-12-01 |
Epizyme Inc |
Amine-substituted aryl or heteroaryl compounds as ehmt1 and ehmt2 inhibitors
|
|
WO2018067704A1
(en)
|
2016-10-04 |
2018-04-12 |
Enanta Pharmaceuticals, Inc. |
Isoxazole analogs as fxr agonists and methods of use thereof
|
|
US11283028B2
(en)
|
2016-10-05 |
2022-03-22 |
Rohm And Haas Electronic Materials Korea Ltd. |
Organic electroluminescent compound and organic electroluminescent device comprising the same
|
|
WO2018108110A1
(zh)
|
2016-12-13 |
2018-06-21 |
广州华睿光电材料有限公司 |
金属有机配合物及其应用、混合物、有机电子器件
|
|
GB201700814D0
(en)
|
2017-01-17 |
2017-03-01 |
Liverpool School Tropical Medicine |
Compounds
|
|
TW201843143A
(zh)
|
2017-03-13 |
2018-12-16 |
德商麥克專利有限公司 |
含有芳基胺結構之化合物
|
|
WO2018169352A1
(en)
|
2017-03-16 |
2018-09-20 |
Rohm And Haas Electronic Materials Korea Ltd. |
Organic electroluminescent device
|
|
KR102335935B1
(ko)
|
2017-03-22 |
2021-12-06 |
덕산네오룩스 주식회사 |
유기전기소자용 화합물, 이를 이용한 유기전기소자 및 그 전자 장치
|
|
WO2018183923A1
(en)
|
2017-03-31 |
2018-10-04 |
Epizyme, Inc. |
Methods of using ehmt2 inhibitors
|
|
KR102389204B1
(ko)
|
2017-04-18 |
2022-04-21 |
덕산네오룩스 주식회사 |
유기전기 소자용 화합물, 이를 이용한 유기전기소자 및 그 전자 장치
|
|
WO2018195450A1
(en)
|
2017-04-21 |
2018-10-25 |
Epizyme, Inc. |
Combination therapies with ehmt2 inhibitors
|
|
WO2018204765A1
(en)
|
2017-05-05 |
2018-11-08 |
Pairnomix, Llc |
Methods of treating epilepsy and kcnq2 related conditions
|
|
EP3638230A4
(en)
|
2017-06-13 |
2021-04-21 |
Commonwealth Scientific and Industrial Research Organisation |
Antiviral drugs
|
|
JPWO2019065516A1
(ja)
|
2017-09-26 |
2020-09-10 |
日本曹達株式会社 |
キノリン化合物および農園芸用殺菌剤
|
|
CA3081946A1
(en)
|
2017-10-18 |
2019-04-25 |
Epizyme, Inc. |
Methods of using ehmt2 inhibitors in preventing or treating blood disorders
|
|
US20210213014A1
(en)
|
2017-10-18 |
2021-07-15 |
Epizyme, Inc. |
Methods of using ehmt2 inhibitors in immunotherapies
|
|
CN108484680B
(zh)
|
2018-01-31 |
2020-12-11 |
马鞍山南京大学高新技术研究院 |
一类双硫代芳环/芳杂环磷酸化合物作为辅助配体的铱配合物
|
|
MX2020010836A
(es)
*
|
2018-05-04 |
2021-01-08 |
Amgen Inc |
Inhibidores de kras g12c y métodos para su uso.
|
|
US12453279B2
(en)
|
2018-08-22 |
2025-10-21 |
Universal Display Corporation |
Organic electroluminescent materials and devices
|
|
CN109265457A
(zh)
|
2018-11-01 |
2019-01-25 |
中国药科大学 |
一种利用氧化芳构化构建吡啶并嘧啶二酮骨架的新方法
|
|
EP3966208A4
(en)
|
2019-05-10 |
2024-01-03 |
Antidote IP Holdings, LLC |
COMPOUNDS AND METHODS OF TREATING CANCER
|
|
CN110283171A
(zh)
|
2019-07-17 |
2019-09-27 |
鼎泰(南京)临床医学研究有限公司 |
一类含有吡啶并嘧啶-4-胺类结构的化合物、药物组合物以及其应用
|
|
US11820783B2
(en)
|
2019-09-06 |
2023-11-21 |
Universal Display Corporation |
Organic electroluminescent materials and devices
|
|
JP7741100B2
(ja)
|
2020-05-04 |
2025-09-17 |
アムジェン インコーポレイテッド |
ミエロイド細胞に発現するトリガー受容体２アゴニストとしての複素環化合物及び使用方法
|
|
WO2021224802A1
(en)
|
2020-05-04 |
2021-11-11 |
Adama Makhteshim Ltd. |
Mixtures and compositions comprising 5-fluoro-4-imino-3- methyl-1-tosyl-3,4-dihydropyrimidin-2-one, and methods of use thereof
|
|
TW202208355A
(zh)
|
2020-05-04 |
2022-03-01 |
美商安進公司 |
作為骨髓細胞觸發受體2促效劑之雜環化合物及使用方法
|
|
CN115515933A
(zh)
|
2020-05-04 |
2022-12-23 |
武田药品工业株式会社 |
经管腔作用的n-(哌啶-4-基)苯甲酰胺衍生物
|
|
CN111454265B
(zh)
|
2020-05-07 |
2021-08-24 |
宁波卢米蓝新材料有限公司 |
一种稠杂环化合物及其制备方法和应用
|
|
MX2024008594A
(es)
|
2022-01-11 |
2024-09-23 |
Regeneron Pharma |
Variantes del receptor desencadenante expresado en células mieloides 2 (trem2) y usos de estas en el tratamiento de la enfermedad de alzheimer.
|